s 78989,gevokizumab
novartis,natera
['tps3642', 'gevokizumab', 'natera']
stop by our posters presentations today. abstract id: tps3642 - a single-arm phase ii study to evaluate treatment with gevokizumab in patients with stage ii/iii colon cancer who remain ctdna+ after curative surgery and adjuvant chemotherapy #asco22 
Transforming the management of cancer with #Signatera, the personalized test for molecular residual disease detection and recurrence monitoring.